Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy

Wolfgang Stöhr; Sarah Fidler; Myra McClure; Jonathan Weber; David Cooper; Gita Ramjee; Pontiano Kaleebu; Giuseppe Tambussi; Mauro Schechter; Abdel Babiker; Rodney E. Phillips; Kholoud Porter; John Frater

doi:10.1371/journal.pone.0078287

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy

Wolfgang Stöhr, Sarah Fidler, Myra McClure, Jonathan Weber, David Cooper, Gita Ramjee, Pontiano Kaleebu, Giuseppe Tambussi, Mauro Schechter, Abdel Babiker, Rodney E. Phillips, Kholoud Porter, John Frater

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

Objective:A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in primary HIV-1 infection (PHI) maintain viral suppression on stopping. Whether this is related to ART duration has not been explored.Design:And Methods: Using SPARTAC trial data from individuals recruited within 6 months of seroconversion, we present an observational analysis investigating whether duration of ART was associated with post-treatment viraemic control. Kaplan-Meier estimates, logistic regression and Cox models were used.Results:165 participants reached plasma viral loads (VL) 12 weeks compared to ≤12 weeks (p=0.061). Cumulative probabilities of remaining 12 weeks.In multivariable regression, ART for >12 weeks was independently associated with a lower probability of being ≥400 copies/ml within 12 weeks of ART stop (OR=0.11 (95%CI=0.03,0.34), p

Original language	English
Article number	e78287
Journal	PLoS One
Volume	8
Issue number	10
DOIs	https://doi.org/10.1371/journal.pone.0078287
Publication status	Published - Oct 25 2013

ASJC Scopus subject areas

Agricultural and Biological Sciences(all)
Biochemistry, Genetics and Molecular Biology(all)
Medicine(all)

Access to Document

10.1371/journal.pone.0078287

Cite this

Stöhr, W., Fidler, S., McClure, M., Weber, J., Cooper, D., Ramjee, G., Kaleebu, P., Tambussi, G., Schechter, M., Babiker, A., Phillips, R. E., Porter, K., & Frater, J. (2013). Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy. PLoS One, 8(10), [e78287]. https://doi.org/10.1371/journal.pone.0078287

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy. / Stöhr, Wolfgang; Fidler, Sarah; McClure, Myra; Weber, Jonathan; Cooper, David; Ramjee, Gita; Kaleebu, Pontiano; Tambussi, Giuseppe; Schechter, Mauro; Babiker, Abdel; Phillips, Rodney E.; Porter, Kholoud; Frater, John.

In: PLoS One, Vol. 8, No. 10, e78287, 25.10.2013.

Research output: Contribution to journal › Article › peer-review

Stöhr, Wolfgang ; Fidler, Sarah ; McClure, Myra ; Weber, Jonathan ; Cooper, David ; Ramjee, Gita ; Kaleebu, Pontiano ; Tambussi, Giuseppe ; Schechter, Mauro ; Babiker, Abdel ; Phillips, Rodney E. ; Porter, Kholoud ; Frater, John. / Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy. In: PLoS One. 2013 ; Vol. 8, No. 10.

@article{ef22493bc3c64d20a298bc3476fd5426,

title = "Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy",

abstract = "Objective:A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in primary HIV-1 infection (PHI) maintain viral suppression on stopping. Whether this is related to ART duration has not been explored.Design:And Methods: Using SPARTAC trial data from individuals recruited within 6 months of seroconversion, we present an observational analysis investigating whether duration of ART was associated with post-treatment viraemic control. Kaplan-Meier estimates, logistic regression and Cox models were used.Results:165 participants reached plasma viral loads (VL) 12 weeks compared to ≤12 weeks (p=0.061). Cumulative probabilities of remaining 12 weeks.In multivariable regression, ART for >12 weeks was independently associated with a lower probability of being ≥400 copies/ml within 12 weeks of ART stop (OR=0.11 (95%CI=0.03,0.34), p",

author = "Wolfgang St{\"o}hr and Sarah Fidler and Myra McClure and Jonathan Weber and David Cooper and Gita Ramjee and Pontiano Kaleebu and Giuseppe Tambussi and Mauro Schechter and Abdel Babiker and Phillips, {Rodney E.} and Kholoud Porter and John Frater",

year = "2013",

month = oct,

day = "25",

doi = "10.1371/journal.pone.0078287",

language = "English",

volume = "8",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "10",

}

TY - JOUR

T1 - Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy

AU - Stöhr, Wolfgang

AU - Fidler, Sarah

AU - McClure, Myra

AU - Weber, Jonathan

AU - Cooper, David

AU - Ramjee, Gita

AU - Kaleebu, Pontiano

AU - Tambussi, Giuseppe

AU - Schechter, Mauro

AU - Babiker, Abdel

AU - Phillips, Rodney E.

AU - Porter, Kholoud

AU - Frater, John

PY - 2013/10/25

Y1 - 2013/10/25

N2 - Objective:A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in primary HIV-1 infection (PHI) maintain viral suppression on stopping. Whether this is related to ART duration has not been explored.Design:And Methods: Using SPARTAC trial data from individuals recruited within 6 months of seroconversion, we present an observational analysis investigating whether duration of ART was associated with post-treatment viraemic control. Kaplan-Meier estimates, logistic regression and Cox models were used.Results:165 participants reached plasma viral loads (VL) 12 weeks compared to ≤12 weeks (p=0.061). Cumulative probabilities of remaining 12 weeks.In multivariable regression, ART for >12 weeks was independently associated with a lower probability of being ≥400 copies/ml within 12 weeks of ART stop (OR=0.11 (95%CI=0.03,0.34), p

AB - Objective:A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in primary HIV-1 infection (PHI) maintain viral suppression on stopping. Whether this is related to ART duration has not been explored.Design:And Methods: Using SPARTAC trial data from individuals recruited within 6 months of seroconversion, we present an observational analysis investigating whether duration of ART was associated with post-treatment viraemic control. Kaplan-Meier estimates, logistic regression and Cox models were used.Results:165 participants reached plasma viral loads (VL) 12 weeks compared to ≤12 weeks (p=0.061). Cumulative probabilities of remaining 12 weeks.In multivariable regression, ART for >12 weeks was independently associated with a lower probability of being ≥400 copies/ml within 12 weeks of ART stop (OR=0.11 (95%CI=0.03,0.34), p

UR - http://www.scopus.com/inward/record.url?scp=84886401909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886401909&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0078287

DO - 10.1371/journal.pone.0078287

M3 - Article

C2 - 24205183

AN - SCOPUS:84886401909

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e78287

ER -

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this